Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -2449.04% is 1937% below its 5-year average of -120.25%, near the high end of its 5-year range (-9662.19%–-48.04%).
17.11% above its 12-month average of -2954.61%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -896.94%.
NET PROFIT MARGIN
-2449.04%
NET PROFIT MARGIN AVG TTM
-2954.61%
NET PROFIT MARGIN AVG 3Y
-339.36%
NET PROFIT MARGIN AVG 5Y
-120.25%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+17.11%
CURRENT VS 3Y AVG
-621.66%
CURRENT VS 5Y AVG
-1936.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.16%
median of 854 covered companies
CURRENT VS SECTOR MEDIAN
-1530550.00%
vs the sector median at left
iSpecimen Inc.
Market Cap
$2.77M
Net Profit Margin
-2449.04%
TTM Avg
-2954.61%
3Y Avg
-339.36%
5Y Avg
-120.25%
Market Cap
$2.84M
Net Profit Margin
-20.56%
TTM Avg
-29.23%
3Y Avg
-24.83%
5Y Avg
-8.51%
Market Cap
$2.62M
Net Profit Margin
-123.38%
TTM Avg
-169.81%
3Y Avg
-184.41%
5Y Avg
-199.55%
Market Cap
$2.54M
Net Profit Margin
-257.33%
TTM Avg
-169.26%
3Y Avg
-42605.81%
5Y Avg
-28403.87%
Market Cap
$3.01M
Net Profit Margin
-3089.55%
TTM Avg
-3099.32%
3Y Avg
-6095.20%
5Y Avg
-22555.36%
Market Cap
$2.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.04M
Net Profit Margin
0.00%
TTM Avg
-9993.13%
3Y Avg
-11306.74%
5Y Avg
-8768.57%
Market Cap
$3.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.47M
Net Profit Margin
-131.76%
TTM Avg
-396.75%
3Y Avg
-403.38%
5Y Avg
-531.17%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.77M | -2449.04% | -2954.61% | -339.36% | -120.25% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.84M | -20.56% | -29.23% | -24.83% | -8.51% |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -123.38% | -169.81% | -184.41% | -199.55% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -257.33% | -169.26% | -42605.81% | -28403.87% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | -3089.55% | -3099.32% | -6095.20% | -22555.36% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | 0.00% | -9993.13% | -11306.74% | -8768.57% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | -131.76% | -396.75% | -403.38% | -531.17% |
| IceCure Medical Ltd (ICCM)vs › | $3.12M | -427.67% | -455.53% | -478.79% | -375.12% |
Operating Margin
-465.4%
Net Profit Margin
-2449.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -896.94% |
| 2026-03-31 | -1458.39% |
| 2025-12-31 | -9662.19% |
| 2025-09-30 | -2608.68% |
| 2025-06-30 | -146.85% |
| 2025-03-31 | -156.82% |
| 2024-12-31 | -409.81% |
| 2024-09-30 | -54.09% |
| 2024-06-30 | -73.65% |
| 2024-03-31 | -126.73% |
| 2023-12-31 | -119.33% |
| 2023-09-30 | -76.00% |
| 2023-06-30 | -214.36% |
| 2023-03-31 | -82.43% |
| 2022-12-31 | -72.92% |
| 2022-09-30 | -119.62% |
| 2022-06-30 | -111.46% |
| 2022-03-31 | -94.64% |
| 2021-12-31 | -80.44% |
| 2021-09-30 | -57.13% |
| 2021-06-30 | -48.04% |
| 2021-03-31 | -133.73% |
| 2020-12-31 | -58.64% |
| 2020-09-30 | -55.39% |
| 2020-06-30 | -11.57% |
| 2020-03-31 | -95.70% |
| 2019-12-31 | -104.52% |
| 2019-09-30 | -304.02% |
